What Bioserv Life Sciences does

Bioserv Life Sciences is a privately-held Brazilian clinical research services company headquartered in Passo Fundo, Rio Grande do Sul, operating as an integrated Site Management Organization (SMO), Contract Research Organization (CRO), and Patient Management Organization (PMO). The company was founded circa 2008–2010 and currently employs approximately 20 clinical and administrative professionals. It serves pharmaceutical sponsors, CROs, and partner hospitals and clinics across three Brazilian regions — Rio Grande do Sul, São Paulo, and Santa Catarina — managing clinical trial execution end-to-end across more than 15 therapeutic areas including oncology, cardiology, pneumology, neurology, hematology, and gastroenterology.

The company's core technology asset is the CRIO platform, a proprietary digital system that integrates Clinical Trial Management System (CTMS), Electronic Data Capture / eSource, and eRegulatory capabilities into a single paperless environment. CRIO was developed from internal operational experience managing research centers and is also commercially represented by Bioserv to external research sites. The company augments recruitment capabilities through a partnership with Clinerion, an AI-powered patient-database matching solution operating under Brazilian LGPD data protection guidelines. Bioserv also owns and operates Instituto Méderi, a wholly-owned clinical research center that functions as both a recruitment asset and an in-house validation environment for its technology.

Bioserv's business model is professional-services based, generating revenue through SMO site management fees, CRO contract research services, and PMO patient recruitment services. It does not publicly disclose pricing, contract structures, or revenue figures. Distribution is direct enterprise sales to sponsors and CROs combined with a partner-network model for hospitals, clinics, and academic institutions. The company markets itself through its corporate website, a clinical-research blog, and social channels on Instagram, Facebook, and LinkedIn.

Name

Bioserv Life Sciences

Legal name

Bioserv Life Sciences

Website

https://bioservlifesciences.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Bioserv Life Sciences is a Brazilian clinical research services company operating as an integrated SMO, CRO, and PMO, serving pharmaceutical sponsors, CROs, and partner hospitals across Rio Grande do Sul, São Paulo, and Santa Catarina with end-to-end trial management powered by its proprietary CRIO platform.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Clinical research services
• Site management organization
• Contract research organization
• Patient recruitment services
• Clinical trial management software

Headquarters

HQ city

Rio Grande Do Sul

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. SMO Services (Site Management Organization): Management of clinical research centers providing complete activities including startup, administrative and financial management, quality assurance, recruitment strategies, and technology solutions. Generates revenue through service fees for managing research center operations.
2. CRO Services (Contract Research Organization): Contract research services for pharmaceutical companies and sponsors requiring clinical trial management, monitoring visits, and data collection and treatment services.
3. PMO Services (Patient Management Organization): Patient management services focused on recruitment and selection of subjects for studies in more than 15 therapeutic areas with specialized professionals.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Bioserv Life Sciences provides full-service SMO, CRO, and PMO clinical research services in Brazil, managing clinical research centers end-to-end, including start-up, administrative and financial management, quality assurance, patient recruitment across more than 15 therapeutic areas, and technology enablement. Its proprietary CRIO platform integrates CTMS, EDC, eSource, and eRegulatory capabilities into a single digital environment, and is also commercially offered to other research centers. The company operates Instituto Méderi, its own clinical research center, and partners with hospitals and clinics across São Paulo, Rio Grande do Sul, and Santa Catarina.

Product overview

Bioserv Life Sciences operates as a full-service clinical research organization offering integrated SMO, CRO, and PMO services throughout Brazil. The core technology product is the CRIO platform—a unified digital system combining CTMS (Clinical Trial Management System) and EDC/eSource (electronic data capture) capabilities with eRegulatory management, all in a single paperless environment. CRIO serves as both the company's proprietary technology and a commercial product offered to other research centers. The company also partners with Clinerion for AI-powered patient-database matching. Patient recruitment services span more than 15 therapeutic areas across partner centers in Sao Paulo, Rio Grande do Sul, and Santa Catarina.

Differentiator

Problem solved

Functional benefit

Brands

• CRIO: Digital platform developed by Bioserv for clinical research management, integrating CTMS and EDC systems with eSource capabilities for real-time data capture and regulatory compliance.
• Clinerion
• Instituto Méderi

Products and services

• CRIO Platform Proprietary digital platform for clinical research center management that integrates CTMS (Clinical Trial Management System), EDC (Electronic Data Capture), eSource, and eRegulatory capabilities in a single paperless environment. Enables real-time data capture, regulatory compliance, participant management, and remote monitoring for clinical trials. Offered commercially to other research centers as well as used internally by Bioserv.
• SMO Services (Site Management Organization) Full-service site management organization providing complete clinical research center management including start-up activities, administrative and financial management, quality assurance, and recruitment strategies for pharmaceutical sponsors and CROs.
• CRO Services (Contract Research Organization) Contract research organization services for managing clinical trials, partnering with the pharmaceutical industry for research center management, monitoring visits, and consulting services.
• PMO Services (Patient Management Organization) Patient management and recruitment services across more than 15 therapeutic areas, including gastroenterology, oncology, cardiology, pneumology, neurology, and hematology, with specialized professionals connecting patients with clinical research centers in São Paulo, Rio Grande do Sul, and Santa Catarina.
• Instituto Méderi (Clinical Research Center) Proprietary clinical research center initiative promoted by Bioserv Life Sciences to provide greater access to healthcare, better patient care, and increased safety for the population. Located in Rio Grande do Sul with over a decade of clinical research management experience.

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Instituto MédericoreStrategic or Co-development PartnerInstituto Méderi de Pesquisa e Saúde is an initiative of Bioserv Life Sciences to form their own clinical center promoting greater access to healthcare, better care, and more safety for the population. The institute reflects Bioserv's values and quality standards.
• Supera OncologiaminorStrategic or Co-development PartnerPartner organization for oncology research collaboration.
• Valle Pesquisa ClínicaminorStrategic or Co-development PartnerPartner clinical research organization for collaborative studies.
• CIPESminorStrategic or Co-development PartnerPartner organization for clinical research operations.
• Faculdade AtitusminorStrategic or Co-development PartnerAcademic partner for research and talent development.
• ClinerioncoreTechnology or IntegrationClinerion is an AI solution partner that can upgrade patient databases through information cross-referencing with study profiles following LGPD (Brazilian data protection law) guidelines. Bioserv is a commercial representative of this technology.
• CRIO (Clinical Research IO)coreTechnology or IntegrationCRIO is a digital platform for clinical research management that Bioserv uses and represents commercially. It integrates CTMS and EDC systems with eSource and eRegulatory capabilities.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ICON plc: One of the world's largest CROs offering Phase I-IV clinical development, lab, and data services globally. Competes with Bioserv for the same sponsor RFPs at the upper end of the market.
• IQVIA: Largest global CRO and life sciences technology provider with deep site networks in Latin America. Competes head-to-head with Bioserv for CRO and SMO engagements while bundling broader R&D and commercial services.
• Fortrea: Clinical development and commercialization services business spun off from Labcorp in 2023. Direct CRO competitor with global site network and enterprise-scale operations comparable to Bioserv's CRO/SMO offering.
• Charles River Laboratories: Global CRO with research models, discovery, and safety assessment services. While broader than Bioserv, its clinical and site-services segments directly overlap with Bioserv's CRO/SMO positioning.
• Parexel International: Global full-service CRO with significant Phase II/III capability across multiple therapeutic areas. Comparable in CRO service offering; materially larger and broader in geography and data services.

Direct peers

• Worldwide Clinical Trials: Privately-held mid-size global CRO offering full-service clinical development across multiple therapeutic areas. Closely comparable to Bioserv in operating model (CRO services, therapeutic breadth, mid-tier positioning) but with international reach.
• Medpace Holdings: US-based mid-tier CRO with a full-service, technology-enabled clinical development model serving small-to-mid-sized biopharma. Highly comparable business model to Bioserv's CRO+SMO services and proprietary tooling approach, though at much larger scale and in a different geography.
• Clinical Research IO (CRIO): US-based eClinical platform providing eSource, CTMS, and eRegulatory functionality for research sites — the same product category as Bioserv's CRIO platform. Direct technology peer and listed commercial partner.

Regional players

• Meditrial: European-based CRO with dedicated Latin American operations offering clinical trial management and regulatory services across the region. Closest regional peer to Bioserv given overlapping LATAM geographies and mid-tier CRO positioning.

Others

• Clinerion: AI-driven patient-data intelligence platform for clinical trial patient identification. Listed as Bioserv's technology partner and commercial representation arrangement, and a thematic peer in the patient-recruitment technology layer that Bioserv commercializes in Brazil.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Bioservlifesciences
• LinkedInlinkedin.com/company/bioservlifesciences
• Instagraminstagram.com/bioserv.lifesciences

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioserv Life Sciences